Services on Demand
- Cited by SciELO
- Access statistics
- Cited by Google
- Similars in SciELO
- Similars in Google
Print version ISSN 1415-4757
Genet. Mol. Biol. vol.33 no.3 São Paulo 2010 Epub July 02, 2010
Terezinha M.B. de AlmeidaI; Regina Maria C. LeitãoII; Flair J. CarrilhoIII; Shigueko SonoharaI
IDisciplina de Oncologia, Departamento de Radiologia e Oncologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil
IILaboratório de Anatomia Patológica Diagnóstika, São Paulo, SP, Brazil
IIIDisciplina de Gastroenterologia Clínica-Hepatologia, Departamento de Gastroenterologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil
Genetic research on fibrosis outset and its progression in chronic hepatitis (CH) by hepatitis C virus (HCV) are limited. The lack of cytogenetic data led us to investigate the presence of micronuclei (MNi), as a sign of genomic damage. Hepatocytes of hepatic parenchyma from 62 cases diagnosed with CH associated with HCV and displaying different degrees of fibrosis (F1-F4) were analyzed. These data were compared to 15 cases without fibrosis (F0). Twelve healthy liver parenchyma samples were included as control. All samples were obtained from paraffin-embedded archival material. Micronucleated hepatocytes (MN-Heps) were analyzed through Feulgen/Fastgreen staining. Results showed that the rates of MN-Heps in the F4 group were statistically significant (p < 0.05) and higher than those in the control group. Like results were also obtained on comparing F4 with F0, F1, F2 and F3 cases. Conversely, differences were not significant (p > 0.05) on comparing F0, F1, F2, F3, one against the other, as well as individual versus control. Although chromosomal losses in CH were detected, it was shown that liver parenchyma with fibrosis in the initial stages (F1-F3) cannot be considered cytogenetically abnormal.
Key words: micronuclei, hepatocytes, chronic hepatitis C, fibrosis progression, HCV-patients.
Chronic infection by hepatitis C virus (HCV) is both slow and insidious. 80% of HCV individuals are prone to infection worldwide. From these, over 30% develop chronic liver diseases, including cirrhosis, a major risk for developing hepatocellular carcinoma (HCC) (Thomson and Finch, 2005). This possibility is about 17 times higher in HCV infected patients than in uninfected (Donato et al. 2001). However, the evolution of chronic hepatitis (CH) varies in HCV infected patients, due, not only to the time of infection, but also to the extent of fibrosis generated| by hepatic parenchyma during the necro-inflammatory process (Kiyozawa, 2002; But et al., 2008). The elimination of hepatocytes in CH/HCV during the necro-inflammatory process is followed by accelerated cell division, thereby leading to various grades of fibrosis (F1-F4). In spite of this type of cell proliferation induced by chronic lesion, the liver may still be considered functionally competent (Callea et al., 1991). The intense hepatocyte turnover may make all cells susceptible to genetic variation, this including cytogenetic instability, thus creating propitious conditions for the development of the various stages of hepatocarcinogenesis (Kitamura et al., 1998).
There are no data available on chromosomal instability from the onset of the fibrosis progression caused by virus infection in human beings. However, cytogenetic changes in micronucleated hepatocytes (MN-Heps) through chromatin loss were found in CH/HCV-F4 in regenerative cirrhotic nodules without atypia (Almeida et al., 2004; Guido et al., 2008; Kim et al., 2009). Micronuclei may originate either from acentric fragments, resulting from chromosomal/chromatid breaks, or from whole chromosomes, unable to migrate with the remainder chromosomes in anaphase, and being included in one or more secondary nuclei in daughter cells. Thus, MN assays can be used to evaluate clastogenic and aneugenic effects (Heddle et al., 1991; Fenech, 2000). The hypothesis was that micronuclei, as the result of chromosome breakage/anaphase lagging, might occur in CH/HCV at the start of the fibrotic process, and increasing in cirrhosis and in HCC. To check this hypothesis, MN-Hep frequencies inside CH/HCV liver parenchyma with (F1-F4) or without fibrosis (F0) and with normal parenchyma (NP), were examined.
Material and Methods
Liver tissue samples from 89 individuals, both male and female (age 18-60), were analyzed. Study material consisted of hepatocytes in 77 samples from CH|HCV patients without fibrosis (F0), and parenchyma with fibrosis in the initial (F1, F2, F3) and final (F4) stages, as well as samples from twelve healthy donors -NP (control group). All the samples were retrospective from 2002 to 2007, and collected from the Laboratório de Anatomia Patológica Diagnóstika, São Paulo, Brazil. According to clinical references, the patients had not been previously exposed to any kind of etiological agent, including those known as mutagenic.
CH/HCV samples were separated into the following groups: F0 (15); F1 (14); F2 (16); F3 (15); F4 (17), plus 12 control individuals. Retrospective studies were performed on liver samples fixed in 10% formalin and embedded in paraffin blocks. For light microscopy, each sample in paraffin blocks was cut into 3-5 µm-thick sections and stained with hematoxylin-eosin in order to choose the areas to be studied. The fibrosis-stage for investigation in each case was determined by the histological characteristics imputed by both the METAVIR system (The French METAVIR Cooperative Study Group, 1994) and International Working Party (1995). These are: F0-without fibrosis; F1-mild fibrosis; F2-moderate fibrosis; F3-severe fibrosis and F4cirrhosis in regenerative nodules (RNs) without atypia. The normal hepatic parenchyma was chosen at random. After establishing these areas the samples were prepared for MN-Heps analysis.
Detection of micronuclei
Slides were stained by the Feulgen reaction and counterstained with fast-green, as described by Almeida et al. (2004). Each slide was code-labeled, so as to avoid observer bias, and examined at 1250x magnification with a standard optical microscope (Olympus BX-50). The number of hepatocytes scored was usually 2000 per sample. The same criteria described by Almeida et al. (2004) were used for evaluating MN-Heps. This cytogenetic evaluation was carried out with 178,000 mononucleated hepatocytes from the following chronic hepatitis parenchyma (CHP) groups: 30,000 (F0); 28,000 (F1); 32,000 (F2); 30,000 (F3) and 34,000 (F4), besides 24,000 with normal parenchyma (NP). The results were all expressed according to the number of MN-Heps per 1000 hepatocytes (‰).
Since data were not normally distributed, differences among groups were checked through nonparametric analysis of variance (Kruskall-Wallis test), followed by a multiple comparisons test in order to locate those comparisons responsible for significance of the test. Commercial (SPSS Inc., Chicago, IL, USA) and public domain (Online R Development Team, 2009) softwares were used for all mentioned statistical analyses.
The distribution of micronuclei (MNi) per hepatocyte in the F0, F1, F2, F3 and F4 groups, irrespective of parenchymal area, and even in the NP (control group) indicated only one MN in most cells (95.6%), as shown in Figure 1A, B, C. In the F0 group, in about 22% of the cases, incidence was one or two MNi per cell (Figure 1D), the same occurring in the F3 and F4 groups, although, in the control group, in 30% of the cells, this was one to three MNi. In most NP cells, incidence was one MN per cell, although 6 hepatocytes with two MNi each were also found. The MN-Heps evaluated in the parenchyma of each group were of different sizes. In F0-F3 groups size mostly varied from medium (1/10 diameter of the main nucleus) to large (1/5) (Figure 1C, D). In F4, most MNi small-sized (1/15), even when there were two (Figure 1A, B). MN-Hep frequencies were obtained from CHP in different stages of fibrosis (F1, F2, F3, F4), as well as parenchyma without fibrosis (F0) and in NP. Median values (range) were distributed, as follows: F0: 6 (1-14),N=15; F1: 5 (2-15), N = 14; F2: 7 (1-11), N = 16; F3: 6 (1-10), N = 15; F4: 11 (4-33),N=17and control: 5.5 (1-9), N = 12, p = 0.001 (Kruskall-Wallis test); (Figure 2). Table 1 shows p values calculated from multiple comparisons of MN-Heps data on NP, as well as the progression of fibrosis (F0 to F4). Only the F4 group showed statistically significant differences (p < 0.05).
To the best of our knowledge, this is the first study on chromatin loss, evaluated by MN formation, in liver samples from patients with CH/HCV during the fibrosis progression. A retrospective study of serial sections enabled us to evaluate CHP samples, which, through being particularly homogeneous, assured the detection of MN-Hep frequency. The results are consistent with the hypothesis that cytogenetic instability is already present in the initial stages of fibrosis, although the alterations in CHP (F1, F2, F3) differed neither mutually nor significantly, not even in those without fibrosis (F0) or in NP. On the contrary, the rate of MN-Heps in cirrhotic parenchyma (F4) was higher and different (p < 0.05) from F0, F1, F2 and F3, even though 93%-100% of the F1, F2, F3, F4 analyzed cases were with A1 and A2 inflammatory activity. Due to cirrhosis complexity, it is suggested that the long period of inflammation, inherent in HCV, may have caused an increase in proliferation, this contributing to the formation of MNi. Most of the MNi found in all cases of CH/HCV were medium to large sized, as already described in our previous work on HCV cirrhosis (Almeida et al. 2004). Oxidative and nitrosactive stress in CH/HCV (Choi and Ou, 2006; Seronello et al., 2007) may cause both genotoxicity and, mutagenicity in hepatocytes. This phenomenon may create chromosomal instability (MN formation) in the diverse stages of fibrotic development in various ways (clastogenicity -chromatid breaks and/or aneugenicity -chromosome loss). The formation of MN by clastogenicity mechanisms has already been shown in genotoxic-induced hepatomas (Canonero et al., 1997; Sanyal et al., 1997), as well as in the evaluation of aneugenic substances (Fimognari et al., 1997). The loss of spindle assembly checkpoints often occurs with a high frequency in HCC with chromosomal instability (Saeki et al., 2002). The formation of MNi originating from several chromosomes was also obtained in human hepatoma HepG2 cells transfected with hepatitis B virus (HBV)-X genes, thereby providing evidence of alterations in genomic integrity (Livezey et al., 2002). Studies of liver-cell lines showed that overexpression in hepatitis C virus NS5A protein is also directly involved in the formation of chromosome instability by mitotic cycle disregulation (Baek et al., 2006). Thus, it is possible that the hypercarcinogenic state, due to chronic HCV infection (Hino et al., 2002), might be associated with several genetic and epigenetic events, thereby explaining the presence of different-sized MN. Nevertheless, there was no relationship between MNi detected during fibrosis progression and changes in CHP morphological characteristics. We consider that the offset and increase in premature cytogenetic instability may play an important role in the innumerable lesions arising during CH/HCV evolution towards F4 (cirrhosis). A further conclusion of this work concerns the apparent cytogenetic normality of fibrotic parenchyma (F1-F3) in spite of chromosome loss evidenced by MN formation in liver hepatocytes during the development of CH/HCV.
This work was supported by grants from the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Sense Indústria e Comércio Ltda., Centro de Estudos em Gastroenterologia -Agostinho Betarello, and the Alves de Queiróz Family Fund for Research. We are grateful to Helena Khouri for English language revision, João Italo Dias França for the revision of statistical analyses and Maria Cristina Granero Grandal for figure editing.
Almeida TMB, Leitão RC, Andrade JD, Beçak W, Carrilho FJ and Sonohara S (2004) Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma. Cancer Genet Cytogenet 150:16-21. [ Links ]
Baek K-H, Park H-Y, Kang C-M, Kim S-J, Jeong S-J, Hong E-K, Park J-W, Sung Y-C, Suzuki T, Kim C-M, et al. (2006) Overexpression of hepatitis C virus NS5A protein induces chromosome instability via mitotic cell cycle dysregulation. J Mol Biol 350:22-34. [ Links ]
But DY-K, Lai C-L and Yuen M-F (2008) Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol 14:1652-1656. [ Links ]
Callea F, Brisigotti M, Fabbretti G, Sciot R, Van Eiken P and Fabret M (1991) Cirrhosis of the liver: A regenerative process. Dig Dis Sci 36:1287-1293. [ Links ]
Canonero R, Campart GB, Mattioli F, Robbiano L and Martelli A (1997) Testing of p-dichlorobenzene and hexachlorofeno for their ability to induce DNA damage and micronucleus formation in primary cultures of rat and human hepatocytes. Mutagenesis 12:35-39. [ Links ]
Choi J and Ou J-HJ (2006) Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 290:G847-851. [ Links ]
Donato MF, Arosio E, Del Ninno E, Ronchi G, Lampertico P, Morabito A, Balestrieri MR and Colombo M (2001) High rates of hepatocellular carcinoma in cirrhotic patiens with high liver cell proliferative activity. Hepatology 34:523-528. [ Links ]
Fenech M (2000) The in vitro micronucleus technique. Mutat Res 455:81-95. [ Links ]
Fimognari C, Sauer-Nehls S, Braselmann H and Nüsse M (1997) Analysis of radiation-induced micronuclei by FISH M Micronuclei and broken eggs in liver carcinogenesis using a combination of painting and centromeric DNA probes. Mutagenesis 12:91-95. [ Links ]
Guido M, Fassan M, Giacomelli L, Cillo U, Farinati F, Burra P, Fadiuoli S and Rugge M (2008) Micronuclei and broken eggs in liver carcinogenesis. Anticancer Res 28:2507-2512. [ Links ]
Heddle JA, Cimino MC, Hayashi M, Romagna F, Shelby MD, Tucker JD, Vamparys P and MacGrego JT (1991) Micronuclei as an index of cytogenetic damage: Past, present, and future. Environ Mol Mutagen 18:277-291. [ Links ]
Hino O, Kajino K, Umeda T and Arakawa Y (2002) Understanding the hypercarcinogenic state in chronic hepatitis: A clue to the prevention of human hepatocellular carcinoma. J Gastroenterol 37:883-887. [ Links ]
International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983-993. [ Links ]
Kim H, OH BK, Park C, Yoon SM, Yoo JE and Park YN (2009) Large liver cell change in hepatitis B virus-related liver fibrosis. Hepatology 50:752-762. [ Links ]
Kitamura T, Watanabe S and Sato N (1998) Liver regeneration, liver cancer and cyclins. J Gastroenterol Hepatol 13:S96-99. [ Links ]
Kiyozawa K (2002) Trend of liver cirrhosis as precancerous lesions. Hepatol Res 24:40-45. [ Links ]
Livezey KW, Negorev D and Simon D (2002) Increased chromosomal alterations and micronuclei formation in human hepatoma HepG2 cells transfected with the hepatitis B virus HBX gene. Mutat Res 505:63-74. [ Links ]
Saeki A, Tamura S, Ito N, Kiso S, Matsuda Y, Yabuuchi I, Kawata S and Matsuzawa Y (2002) Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma. Cancer 94:2047-2054. [ Links ]
Sanyal R, Darroudi F, Parzefall W, Nagao M and Knasmüller S (1997) Inhibition of genotoxic effects of heterocyclic amines in human derived hepatoma cells by dietary bioantimutagens. Mutagenesis 12:297-303. [ Links ]
Seronello S, Sheikh MY and Choi J (2007) Redox regulation of hepatitis C in nonalcoholic and alcoholic liver. Free Rad Biol Med 43:869-882. [ Links ]
The French METAVIR Cooperative Study Group (1994) Intraobserver and interobserver variations in the assessment of liver biopsy of chronic hepatitis C. Hepatology 20:15-20. [ Links ]
Thomson BJ and Finch RG (2005) Hepatitis C infection. Clin Microbiol Infect 11:86-94. [ Links ]
Online R Development Team (2009) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. http://www.R-project.org (September 11, 2009). [ Links ]
Send correspondence to:
Departamento de Radiologia, Faculdade de Medicina, Universidade de São Paulo
Av. Dr. Arnaldo 455, 4º andar, sala 4121
01246-903 São Paulo, SP, Brazil
Received: July 21, 2009; Accepted: February 23, 2010.
Associate Editor: Paulo A. Otto
License information: This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.